Current Management of Invasive and Metastatic Transitional Cell Carcinoma of the Bladder
- 1 May 1993
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 149 (5 Part 1) , 957-972
- https://doi.org/10.1016/s0022-5347(17)36270-5
Abstract
No abstract availableThis publication has 106 references indexed in Scilit:
- Bladder cancerCurrent Problems in Cancer, 1990
- Neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin for locally advanced transitional cell carcinoma of the bladderCancer, 1990
- Neodymium‐YAG Laser Irradiation of Stage T2 Muscle‐invasive Bladder Cancer. Long‐term ResultsBritish Journal of Urology, 1990
- Neo‐adjuvant Chemotherapy for Invasive Bladder Cancer. Experience with the M‐VAC RegimenBritish Journal of Urology, 1989
- Intraarterial cisplatin infusion in the management of transitional cell carcinoma of the bladderCancer, 1989
- Effect of Granulocyte Colony-Stimulating Factor on Neutropenia and Associated Morbidity Due to Chemotherapy for Transitional-Cell Carcinoma of the UrotheliumNew England Journal of Medicine, 1988
- The Will Rogers PhenomenonNew England Journal of Medicine, 1985
- Radical Prostatectomy and Cystoprostatectomy with Preservation of Potency. Results Using a New Nerve‐sparing TechniqueBritish Journal of Urology, 1984
- THE ROLE OF CONSERVATIVE SURGERY IN THE TREATMENT OF BLADDER TUMOURS 1British Journal of Urology, 1954